<http://schema.org/description>
"British pharmaceuticals giant GlaxoSmithKline has agreed a $350-million deal with Adaptimmune to help develop and sell the biotechnology firm's cancer drugs, the companies said on Monday."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2014-06-glaxo-350mln-cancer-biotech-specialist.html>